Lumenis M22™

The Lumenis M22 IPL works by focusing the correct light pulses into the Meibomian glands and surrounding tissue including small, abnormal vessels, the root cause of dry eye problems. This FDA-approved treatment makes use of the oxyhemoglobin in the blood vessels which absorbs the light emitted by the IPL machine.

​

WHAT CAN I EXPECT DURING TREATMENT?

This painless, non-invasive procedure requires no anesthesia, sedation, or pre-operative testing. Patients can drive and return to full activities immediately, including unlimited exercise, swimming, and reading. There is no post-operative discomfort and no decrease in vision.

​

​WHEN WILL I SEE RESULTS?

Patients frequently recognize an improvement in symptoms after a single treatment. A permanent change in Meibomian gland function requires four monthly treatments the first year and a maintenance treatment once a year thereafter.

​

<< BACK TO ALL DRY EYE TREATMENTS

​

​